Core Laboratories (CLB) PT Raised to $21 at Cowen

Cowen analyst Marc Bianchi raised the price target on Core Laboratories (NYSE: CLB) to $21.00 (from $20.00) while maintaining a Market Perform rating.

The analyst commented, "CLB outperformed the OIH by 85bps after a 1Q beat but weaker than expected FCF. International commentary remains positive with a growing list of new projects. While guided 2Q revenue growth appears robust, cost absorption relating to furlough program unwind weighs on incremental margins in the near to mid-term and therefore limits any positive revision to our estimates. Maintain Market Perform."

You May Also Be Interested In

• argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'